CanCOLD deepens our understanding of mild-to-moderate COPD and helps identify novel risk factors, reliable diagnostics for early detection of COPD, and helps us appropriately quantify COPD prevalence. Research using CanCOLD data advances clinical practice, guidelines and health policies for the benefit of COPD patients.